The Joint Congress of ESPE and ESE 2025 would like to thank the following industry partners for their confirmed support at the 2025 Congress in Copenhagen. (as per February 2025)
Platinum
Ascendis Pharma
Merck
Novo Nordisk
Gold
XX
XX
XX
Bronze
Camurus
Chiesi
Crinetics Pharmaceuticals
Diurnal/Neurocrine Biosciences
Inozyme
Kyowa Kirin
Recordati Rare Diseases
XX
Supporter
Exhibitors
Arrowhead Pharma
Because Hormones Matter
Biocartis
Bioscientifica
BoneXpert
Clarius
Egetis Therapeutics
Endocrine Society
EndoBridge
Endo-ERN
European Society of Endocrinology (ESE)
European Society for Paediatric Endocrinology (ESPE)
Growth Analyser
HypoPARAthyroidism Association Inc
International Society of Endocrinology (ISE)
International Society for Pediatric and Adolescent Diabetes (ISPAD)
Karger
Lumos Pharma
Metabolon
Nightingale Health
Office for Rare Conditions
Oxford University Press
PC Pal
SERB Pharmaceuticals
Sociedade Brasileira de Endocrinologia e Metabologia (SBEM)
Sonoscanner
Wisepress
Visit our sponsors and exhibitors during the congress in the exhibition area in hall E of the Bella Centre in Copenhagen.
i-Care World
Ipsen
Lumos Pharma
EthicalMedTech
Interplan is certified as a MedTech Ethical Charter Trusted Partner. Interplan supports by offering the advantages to MedTech Europe member companies, medical societies, and conference venues.
The Trusted Partner will organize its Educational Events in accordance with the rules of the MedTech Europe Code.
The Trusted Partner will require that its employees and other individuals acting on its behalf comply with the MedTech Europe Code when interacting with medical technology industry in the Territory.
The Joint Congress of ESPE and ESE 2025 has applied for Ethical Medtech application following the terms and conditions of Ethical Medtech 1 November 2024 and has been approved as COMPLIANT. For further information, please see the website of Ethical MedTech and the INTERPLAN Compliance Fundamentals.